Louise Rodino-Klapac - Mar 6, 2023 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Signature
/s/ Ryan Brown, as Attorney-in-Fact for Louise Rodino-Klapac
Stock symbol
SRPT
Transactions as of
Mar 6, 2023
Transactions value $
-$178,276
Form type
4
Date filed
3/8/2023, 07:00 PM
Previous filing
Mar 3, 2023
Next filing
Mar 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Tax liability -$178K -1.13K -1.67% $157.21 66.6K Mar 6, 2023 Direct F1
transaction SRPT Common Stock Award $0 +4.5K +6.76% $0.00 71.1K Mar 6, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Stock Option (right to buy) Award $0 +27K $0.00 27K Mar 6, 2023 Common Stock 27K $155.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021.
F2 The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
F3 Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.